Skip to main content
ILMN logo

ILMN · Illumina, Inc. · Webcasts, Transcripts & Audio

Track ILMN — free
$192.82 -7.84 (-3.90%) At close · Nov 20 Q1 2026 earnings call transcript
Market Cap
$29.15B
Shares
151.20M
Volume · Nov 20 1.96M Avg daily vol (3M) 2.81M

Illumina, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Illumina, Inc. (ILMN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-11-17
Illumina, Inc. (ILMN) November 17, 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-10
Illumina, Inc. (ILMN) November 10, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-10-29
Illumina, Inc. (ILMN) Q3 2026 Earnings Call
Revenue
$1.13B
▲ 4.2% YoY
Diluted EPS
$1.43
▲ 45.9% YoY
Gross margin
73.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-07-30
Illumina, Inc. (ILMN) Q2 2026 Earnings Call
Revenue
$1.16B
▲ 9.4% YoY
Diluted EPS
$1.35
▼ 9.4% YoY
Gross margin
66.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-04-30
Illumina, Inc. (ILMN) Q1 2026 Earnings Call Transcript
Confident tone Clinical / Sequencing Consumables Growth NovaSeq X Platform Momentum Spatial Competition (10x Genomics)
Revenue
$1.09B
▲ 4.8% YoY
Diluted EPS
$0.87
▲ 6.1% YoY
Gross margin
66.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-05
Illumina, Inc. (ILMN) Q4 2025 Earnings Call Transcript
Confident tone China / Greater China Research Market / Funding Margins & Capital Return
Revenue
$1.16B*
▲ 5% YoY
Gross margin
65.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-30
Illumina, Inc. (ILMN) Q3 2025 Earnings Call Transcript
Positive tone China & Export Restrictions Research Market & Funding Clinical Sequencing Growth
Revenue
$1.08B
▲ 0.4% YoY
Diluted EPS
$0.98
▼ 77.8% YoY
Gross margin
67.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-31
Illumina, Inc. (ILMN) Q2 2025 Earnings Call Transcript
Positive tone NovaSeq X transition and platform momentum Clinical market strength NovaSeq 6000 to X customer transition dynamics
Revenue
$1.06B
▼ 4.8% YoY
Diluted EPS
$1.49
Gross margin
65.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Illumina, Inc. (ILMN) Q1 2025 Earnings Call Transcript
Balanced tone China export restrictions Guidance revision and ex-China targets NovaSeq X instrument placements
Revenue
$1.04B
▼ 3.3% YoY
Diluted EPS
$0.82
Gross margin
65.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-06
Illumina, Inc. (ILMN) Q4 2024 Earnings Call Transcript
Positive tone NovaSeq X transition and pull-through China regulatory situation R&D investment strategy
Revenue
$1.10B*
▼ 1.6% YoY
Gross margin
65.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Illumina, Inc. (ILMN) Q3 2024 Earnings Call Transcript
Positive tone Revenue and Regional Performance Operational Excellence and Margins Innovation Pipeline
Revenue
$1.08B
▼ 3.5% YoY
Diluted EPS
$4.42
Gross margin
69.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Illumina, Inc. (ILMN) Q2 2024 Earnings Call Transcript
Balanced tone NovaSeq X transition and pull-through Guidance and outlook Innovation pipeline and M&A
Revenue
$1.11B
▼ 5.4% YoY
Diluted EPS
$-12.48
Gross margin
64.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Illumina, Inc. (ILMN) Q1 2024 Earnings Call Transcript
Positive tone Mid-throughput and competitive dynamics GRAIL resolution and divestiture Multiomics and sample-to-answer expansion
Revenue
$1.08B
▼ 1% YoY
Diluted EPS
$-0.79
▼ 4050% YoY
Gross margin
62.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-08
Illumina, Inc. (ILMN) Q4 2023 Earnings Call Transcript
Balanced tone NovaSeq X platform performance and ramp GRAIL divestiture Consumables growth and pull-through
Revenue
$1.12B*
▲ 3.5% YoY
Gross margin
60.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Illumina, Inc. (ILMN) Q3 2023 Earnings Call Transcript
Revenue
$1.12B
▲ 0.4% YoY
Diluted EPS
$-4.77
Gross margin
61.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Illumina, Inc. (ILMN) Q2 2023 Earnings Call Transcript
Revenue
$1.18B
▲ 1.2% YoY
Diluted EPS
$-1.48
Gross margin
62.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-25
Illumina, Inc. (ILMN) Q1 2023 Earnings Call Transcript
Revenue
$1.09B
▼ 11.1% YoY
Diluted EPS
$0.02
▼ 96.4% YoY
Gross margin
60.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-07
Illumina, Inc. (ILMN) Q4 2022 Earnings Call Transcript
Revenue
$1.08B*
▼ 9.6% YoY
Gross margin
62.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Illumina, Inc. (ILMN) Q3 2022 Earnings Call Transcript
Revenue
$1.11B
▲ 0.6% YoY
Diluted EPS
$-24.26
▼ 1266.3% YoY
Gross margin
64.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Illumina, Inc. (ILMN) Q2 2022 Earnings Call Transcript
Revenue
$1.16B
▲ 3.2% YoY
Diluted EPS
$-3.40
▼ 369.8% YoY
Gross margin
66.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Illumina, Inc. (ILMN) Q1 2022 Earnings Call Transcript
Revenue
$1.22B
▲ 11.9% YoY
Diluted EPS
$0.55
▼ 45% YoY
Gross margin
66.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-10
Illumina, Inc. (ILMN) Q4 2021 Earnings Call Transcript
Revenue
$1.20B*
▲ 25.8% YoY
Gross margin
68.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Illumina, Inc. (ILMN) Q3 2021 Earnings Call Transcript
Revenue
$1.11B
▲ 39.5% YoY
Diluted EPS
$2.08
▲ 71.9% YoY
Gross margin
69.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Illumina, Inc. (ILMN) Q2 2021 Earnings Call Transcript
Revenue
$1.13B
▲ 77.9% YoY
Diluted EPS
$1.26
▲ 293.8% YoY
Gross margin
71.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-27
Illumina, Inc. (ILMN) Q1 2021 Earnings Call Transcript
Revenue
$1.09B
▲ 27.2% YoY
Diluted EPS
$1.00
▼ 14.5% YoY
Gross margin
69.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-11
Illumina, Inc. (ILMN) Q4 2020 Earnings Call Transcript
Revenue
$953.00M*
▲ 0% YoY
Gross margin
66.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-29
Illumina, Inc. (ILMN) Q3 2020 Earnings Call Transcript
Revenue
$794.00M
▼ 12.5% YoY
Diluted EPS
$1.21
▼ 23.4% YoY
Gross margin
66.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Illumina, Inc. (ILMN) Q2 2020 Earnings Call Transcript
Revenue
$633.00M
▼ 24.5% YoY
Diluted EPS
$0.32
▼ 83.9% YoY
Gross margin
67.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-30
Illumina, Inc. (ILMN) Q1 2020 Earnings Call Transcript
Revenue
$859.00M
▲ 1.5% YoY
Diluted EPS
$1.17
▼ 25.5% YoY
Gross margin
72.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-01-29
Illumina, Inc. (ILMN) Q4 2019 Earnings Call
Revenue
$953.00M
▲ 9.9% YoY
Diluted EPS
$1.61
▲ 14.2% YoY
Gross margin
69.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–30 of 30 webcasts
Key facts CIK 1110803 CUSIP 452327109 13F (30d) 1013 filings 924 filers Visit website Investor relations